Global Obesity Market and Competitive Landscape – 2017

Lowest Prices Guaranteed	Publisher	Published Date	SKU
from $3,990	Fore Pharma	August, 2017	FPCI15450482

Lowest Prices Guaranteed
Price	from $3,990
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450482

PDF E-mail From Publisher:	$3,990
Global Site License Fulfilled by Publisher:	$5,650

Research assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Table of Contents
Description

Global Obesity Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Obesity Market and Competitive Landscape – 2017, provides comprehensive insights into Obesity pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Obesity market size and drug sales. This research also provides insights into Obesity epidemiology and late stage pipeline.
The report is classified into twelve sections – Obesity overview with definitions, symptoms, etiology, diagnosis, treatment options; Obesity pipeline insights covering late stage clinical trials pipeline; Obesity prevalence trends by countries; Obesity market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

Obesity pipeline: Find out the drugs in clinical trials for Obesity by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Obesity epidemiology: Find out the prevalence of Obesity by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Obesity products: Identify key products marketed and prescribed for Obesity by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Obesity market size: Find out the market size for Obesity drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Obesity drug sales: Find out the sales of Obesity drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
Obesity drugs sales forecast: Sales forecast for Obesity drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Obesity market share analysis: Find out the market shares of Obesity drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Obesity drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Obesity market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Obesity market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Obesity: Disease Overview: 1.1. Obesity Symptoms; 1.2. Obesity Etiology; 1.3. Obesity Diagnosis; 1.4. Obesity Treatment Options
2. Obesity Pipeline Insights: 2.1. Obesity Phase 3 Clinical Trials; 2.2. Obesity Phase 2 Clinical Trials; 2.3. Obesity Phase 1 Clinical Trials
3. Obesity Epidemiology Analysis
4. US Obesity Market Insights: 4.1. Marketed Products for Obesity in US; 4.2. US Obesity Market Size & Forecast; 4.3. US Obesity Product Sales Forecast; 4.4. US Obesity Market Share Analysis
5. Germany Obesity Market Insights: 5.1. Marketed Products for Obesity in Germany; 5.2. Germany Obesity Market Size & Forecast; 5.3. Germany Obesity Product Sales Forecast; 5.4. Germany Obesity Market Share Analysis
6. France Obesity Market Insights: 6.1. Marketed Products for Obesity in France; 6.2. France Obesity Market Size & Forecast; 6.3. France Obesity Product Sales Forecast; 6.4. France Obesity Market Share Analysis
7. Italy Obesity Market Insights: 7.1. Marketed Products for Obesity in Italy; 7.2. Italy Obesity Market Size & Forecast; 7.3. Italy Obesity Product Sales Forecast; 7.4. Italy Obesity Market Share Analysis
8. Spain Obesity Market Insights: 8.1. Marketed Products for Obesity in Spain; 8.2. Spain Obesity Market Size & Forecast; 8.3. Spain Obesity Product Sales Forecast; 8.4. Spain Obesity Market Share Analysis
9. UK Obesity Market Insights: 9.1. Marketed Products for Obesity in UK; 9.2. UK Obesity Market Size & Forecast; 9.3. UK Obesity Product Sales Forecast; 9.4. UK Obesity Market Share Analysis
10. Europe Obesity Market Insights: 10.1. Europe Obesity Market Size & Forecast; 10.2. Europe Obesity Product Sales Forecast; 10.3. Europe Obesity Market Share Analysis
11. Japan Obesity Market Insights: 11.1. Marketed Products for Obesity in Japan; 11.2. Japan Obesity Market Size & Forecast; 11.3. Japan Obesity Product Sales Forecast; 11.4. Japan Obesity Market Share Analysis
12. Global Obesity Market Insights: 12.1. Global Obesity Market Size & Forecast; 12.2. Global Obesity Product Sales Forecast; 12.3. Global Obesity Market Share Analysis
13. Research Methodology
LIST OF TABLES: Table 1: Obesity Phase 3 Clinical Trials, Global, 2017; Table 2: Obesity Phase 2 Clinical Trials, Global, 2017; Table 3: Obesity Phase 1 Clinical Trials, Global, 2017; Table 4: Obesity Prevalence by G7 Countries, 2012 - 2021; Table 5: Marketed Products for Obesity in US, 2017; Table 6: US Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 7: US Obesity Product Sales ($mn), 2012 - 2021; Table 8: US Obesity Market Trends, 2012 - 2021; Table 9: Marketed Products for Obesity in Germany, 2017; Table 10: Germany Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 11: Germany Obesity Product Sales ($mn), 2012 - 2021; Table 12: Germany Obesity Market Trends, 2012 - 2021; Table 13: Marketed Products for Obesity in France, 2017; Table 14: France Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 15: France Obesity Product Sales ($mn), 2012 - 2021; Table 16: France Obesity Market Trends, 2012 - 2021; Table 17: Marketed Products for Obesity in Italy, 2017; Table 18: Italy Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 19: Italy Obesity Product Sales ($mn), 2012 - 2021; Table 20: Italy Obesity Market Trends, 2012 - 2021; Table 21: Marketed Products for Obesity in Spain, 2017; Table 22: Spain Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 23: Spain Obesity Product Sales ($mn), 2012 - 2021; Table 24: Spain Obesity Market Trends, 2012 - 2021; Table 25: Marketed Products for Obesity in UK, 2017; Table 26: UK Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 27: UK Obesity Product Sales ($mn), 2012 - 2021; Table 28: UK Obesity Market Trends, 2012 - 2021; Table 29: Europe Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 30: Europe Obesity Product Sales ($mn), 2012 - 2021; Table 31: Marketed Products for Obesity in Japan, 2017; Table 32: Japan Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 33: Japan Obesity Product Sales ($mn), 2012 - 2021; Table 34: Japan Obesity Market Trends, 2012 - 2021; Table 35: Global Obesity Market Size & Forecast ($mn), 2012 - 2021; Table 36: Global Obesity Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Obesity Pipeline by Phase (%), Global, 2017; Figure 2: Obesity Prevalence by G7 Countries, 2012 - 2021; Figure 3: US Obesity Market Size ($mn), 2012 - 2021; Figure 4: US Obesity Product Sales ($mn), 2012 - 2021; Figure 5: US Obesity Market Share by Products (%), 2016; Figure 6: US Obesity Market - Future Market Share (%), 2021; Figure 7: Germany Obesity Market Size ($mn), 2012 - 2021; Figure 8: Germany Obesity Product Sales ($mn), 2012 - 2021; Figure 9: Germany Obesity Market Share by Products (%), 2016; Figure 10: Germany Obesity Market - Future Market Share (%), 2021; Figure 11: France Obesity Market Size ($mn), 2012 - 2021; Figure 12: France Obesity Product Sales ($mn), 2012 - 2021; Figure 13: France Obesity Market Share by Products (%), 2016; Figure 14: France Obesity Market - Future Market Share (%), 2021; Figure 15: Italy Obesity Market Size ($mn), 2012 - 2021; Figure 16: Italy Obesity Product Sales ($mn), 2012 - 2021; Figure 17: Italy Obesity Market Share by Products (%), 2016; Figure 18: Italy Obesity Market - Future Market Share (%), 2021; Figure 19: Spain Obesity Market Size ($mn), 2012 - 2021; Figure 20: Spain Obesity Product Sales ($mn), 2012 - 2021; Figure 21: Spain Obesity Market Share by Products (%), 2016; Figure 22: Spain Obesity Market - Future Market Share (%), 2021; Figure 23: UK Obesity Market Size ($mn), 2012 - 2021; Figure 24: UK Obesity Product Sales ($mn), 2012 - 2021; Figure 25: UK Obesity Market Share by Products (%), 2016; Figure 26: UK Obesity Market - Future Market Share (%), 2021; Figure 27: Europe Obesity Market Size ($mn), 2012 - 2021; Figure 28: Europe Obesity Product Sales ($mn), 2012 - 2021; Figure 29: Europe Obesity Market Share by Products (%), 2016; Figure 30: Europe Obesity Market - Future Market Share (%), 2021; Figure 31: Japan Obesity Market Size ($mn), 2012 - 2021; Figure 32: Japan Obesity Product Sales ($mn), 2012 - 2021; Figure 33: Japan Obesity Market Share by Products (%), 2016; Figure 34: Japan Obesity Market - Future Market Share (%), 2021; Figure 35: Global Obesity Market Size ($mn), 2012 - 2021; Figure 36: Global Obesity Product Sales ($mn), 2012 - 2021; Figure 37: Global Obesity Market Share by Products (%), 2016; Figure 38: Global Obesity Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Global Obesity Market and Competitive Landscape – 2017

Share this report

Other tasks